Showing results (1801-1810 of 2,013) with videos related to

Sort By:
Pageof 202
Physical Chemistry Chemical Physics : PCCP|June 9, 2018
Direct measurement of Ni incorporation into Fe<sub>3</sub>O<sub>4</sub>(001)P T P Ryan, Z Jakub, J Balajka, et al.
Harmful Algae|September 11, 2018
Diversity and toxicity of Pseudo-nitzschia species in Monterey Bay: Perspectives from targeted and adaptive samplingHolly A Bowers, John P Ryan, Kendra Hayashi, et al.
Genome Medicine|December 28, 2022
The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinicFergus Stafford, Neesha Krishnan, Ebony Richardson, et al.
Contemporary Clinical Trials|October 28, 2022
Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancerKelly E Irwin, Catherine A Callaway, Amy E Corveleyn, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 31, 2020
Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreasClifton Rodrigues, Thomas Hank, Motaz Qadan, et al.
JAMA Oncology|February 10, 2022
Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer: A Randomized Clinical TrialRyan D Nipp, Nora K Horick, Carolyn L Qian, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologiesT Wei, B Liao, B L Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2011
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinomaJ A Chan, L S Blaszkowsky, P C Enzinger, et al.
The Oncologist|September 2, 2017
Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous NeoplasmsJoseph W Franses, Omer Basar, Abdurrahman Kadayifci, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Pageof 202